ArticleInternational journal of MS care

The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis: A Narrative Review and Canadian Regional Reimbursement Policies.

Katherine B Knox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.